Sai Life Sciences is currently trading at Rs. 850.55, up by 39.35 points or 4.85% from its previous closing of Rs. 811.20 on the BSE.

The scrip opened at Rs. 850.45 and has touched a high and low of Rs. 877.25 and Rs. 826.80 respectively. So far 268840 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 983.60 on 07-Jan-2026 and a 52 week low of Rs. 635.30 on 09-Apr-2025.

Last one week high and low of the scrip stood at Rs. 889.85 and Rs. 786.15 respectively. The current market cap of the company is Rs. 18000.12 crore.

The promoters holding in the company stood at 34.70%, while Institutions and Non-Institutions held 52.81% and 12.49% respectively.

Sai Life Sciences has reported 91.21% jump in its net profit at Rs 97.63 crore for the third quarter ended December 31, 2025 (Q3FY26) as compared to Rs 51.06 crore for the same quarter in the previous year. The total income of the company increased by 27.30% at Rs 557.63 crore for Q3FY26 as compared to Rs 438.05 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 86.41% jump in its net profit at Rs 100.38 crore for the third quarter ended December 31, 2025 as compared to Rs 53.85 crore for the same quarter in the previous year. The total income of the company increased by 25.83% at Rs 564.84 crore for Q3FY26 as compared to Rs 448.89 crore for the corresponding quarter previous year.